Form 4: Aethlon Medical Director Forfeits Shares to Cover Tax Withholdings

Sentiment:

SEC Form 4


Director Edward G. Broenniman forfeited 1,645 shares of Aethlon Medical common stock to cover tax obligations upon the conversion of restricted stock units.

Summary

  • On March 31, 2025, Edward G. Broenniman, a director of Aethlon Medical Inc., forfeited 1,645 shares of common stock.
  • The forfeiture was related to the conversion of 8,224 vested restricted stock units into common stock.
  • The shares were forfeited to cover tax withholdings associated with the conversion.
  • The price per share used for the tax withholding calculation was $0.358.
  • Following the transaction, Broenniman beneficially owns 38,884 shares of Aethlon Medical common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation. It is neither particularly positive nor negative.

Industry Context

This transaction is a routine part of executive compensation involving stock-based awards. It reflects the standard practice of covering tax obligations arising from the vesting of restricted stock units.

Stakeholder Impact

  • The forfeiture of shares has a minimal impact on shareholders as it is a standard procedure for covering tax obligations related to executive compensation.

Key Dates

DateDescription
04/17/2023Date of Form 4 filing reporting the grant of restricted stock units.
03/31/2025Date of the transaction where shares were forfeited to cover tax withholdings.
04/01/2025Date of signature on the Form 4 filing.

Keywords

Aethlon Medical, Director, Share Forfeiture, Tax Withholdings, Restricted Stock Units, Beneficial Ownership, AEMD

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.